Review decisions

Showing 60 results of 292 total
Summary Safety Review - Opdivo (nivolumab) - Assessing the Potential Risks of Certain Blood Disorders, and Cytokine Release and Tumor Lysis Syndromes
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00267
Issued / Original Publication Date: 2021-05-19
Updated Date: 2021-06-09
Summary safety review - Janssen COVID-19 Vaccine - Assessing the Potential Risk of Thrombosis in combination with Thrombocytopenia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00266
Issued / Original Publication Date: 2021-05-04
Summary Safety Review - AstraZeneca and COVISHIELD COVID-19 Vaccines - Assessing the Potential Risk of Thrombosis in combination with Thrombocytopenia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00265
Issued / Original Publication Date: 2021-04-19
Summary Safety Review - Veklury (remdesivir) - Assessing the Potential Risks of Acute Kidney Injury (AKI) and Acute Renal Failure (ARF)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00264
Issued / Original Publication Date: 2021-04-09
Summary safety review - Dental Amalgam - Assessing the Potential Risk of Negative Health Effects from Mercury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00263
Issued / Original Publication Date: 2021-03-31
Summary Safety Review - Artemisia annua -containing Products - Assessing the Potential Risk of Liver Injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00262
Issued / Original Publication Date: 2021-03-24
Summary Safety Review - Diuretics, Including Acetazolamide - Assessing the Potential Risk of Certain Eye Disorders
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00261
Issued / Original Publication Date: 2021-03-19
Summary safety review - Remicade (infliximab), Humira (adalimumab), Enbrel (etanercept) and Erelzi (biosimilar etanercept) - Assessing the Potential Risk of Mycosis Fungoides
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00260
Issued / Original Publication Date: 2021-03-18
Summary Safety Review - Cefuroxime-containing products - Assessing the Potential Risk of Kounis Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00259
Issued / Original Publication Date: 2021-03-04
Summary Safety Review - Ceftriaxone-containing products - Assessing the Potential Risk of Encephalopathy
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00257
Issued / Original Publication Date: 2021-02-03

Displaying 51 - 60 of 292 | Page 6 of 30
Report a problem or mistake on this page
Please select all that apply:
Date modified: